NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$12.64 USD
+0.41 (3.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.64 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For NVCR
-
NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?
-
NovoCure (NVCR) Reports Q4 Loss, Tops Revenue Estimates
-
NovoCure: Q4 Earnings Snapshot
-
NovoCure: Q4 Earnings Snapshot
-
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
-
NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates
-
NovoCure: Q3 Earnings Snapshot
-
Novocure Reports Third Quarter 2023 Financial Results
-
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
-
NovoCure: Q2 Earnings Snapshot
-
Novocure Reports Second Quarter 2023 Financial Results
-
NovoCure (NVCR) Reports Q1 Loss, Lags Revenue Estimates
-
NovoCure: Q1 Earnings Snapshot
-
Novocure Reports First Quarter 2023 Financial Results
-
NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates
-
NovoCure: Q4 Earnings Snapshot
-
NovoCure: Q4 Earnings Snapshot
-
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
-
Analysts Estimate NovoCure (NVCR) to Report a Decline in Earnings: What to Look Out for
-
NovoCure (NVCR) Reports Q3 Loss, Lags Revenue Estimates
-
NovoCure: Q3 Earnings Snapshot
-
Novocure Reports Third Quarter 2022 Financial Results
-
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
-
NovoCure: Q2 Earnings Snapshot
-
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates